Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NT 201 dilution comparison in upper limb spasticity
2006-003036-30Phase 3Completed
- Sponsor
- Merz
- Start
- Nov 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of botulinum toxin type A in upper extremity spasticity (2 arms), sponsored by Merz. Primary endpoint: Non-inferiority objective. Started Nov 2006; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
upper extremity spasticity
Beyond the preview
Go deeper on 2006-003036-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003036-30.